Rohrer J W, Kemp J D
J Immunol. 1986 Sep 15;137(6):1786-92.
We have previously provided evidence that the SRBC-immune helper T (TH) cells which enhance MOPC-315 plasmacytoma cell secretory differentiation in vivo (THd cells) differ in specificity, accessory cell requirements, and Qa-1 expression from the SRBC-immune TH cells which enhance MOPC-315 cell growth in vivo (THg cells). Indeed, like other immunoglobulin-dependent TH cells, THd cells in the 315 system do not develop in anti-IgM-treated, B cell-deficient mice, whereas THg cell development is unaffected. In this report, we provide evidence for other differences in the expression of surface antigens by these two TH cell populations. We find that, like most Lyt-1+, 2- T cells, the THg cells can be eliminated by monoclonal anti-L3T4 antibody and complement treatment, whereas such treatment had no effect on adoptive transfer of SRBC-immune THd cell activity. Similarly, THg cell activity was eliminated from SRBC-immune T cells by treatment with monoclonal anti-T cell receptor beta-chain allotope antibody plus anti-rat IgG and complement, whereas THd cell activity remained intact. Both helper cell activities were deleted by either anti-Lyt-1.2 or anti-Thy-1.2 antibody and complement treatment. Interestingly, the THd cell activity was abrogated by treating SRBC-immune T cells with monoclonal anti-B220 or monoclonal anti-p50 antibodies (RA3-3A1/6.1 and RA3-2C2/1, respectively) and complement, whereas THg cell activity was unaffected. Additional controls indicated that the THd effects did not arise by virtue of a two-cell interaction between a Thy-1+, B220- cell and a Thy-1-, B220+ cell, and it is therefore proposed that the THd effect arises from a single population of cells that exhibit a unique phenotype (Thy-1+, Ly-1+, 2-, L3T4-, B220+). The proposal is further supported by studies conducted with a T cell clone which promotes MOPC-315 cell secretory differentiation in vitro and which exhibits this surface antigen phenotype. The serologic differences between these two TH cell populations stress even further the likelihood that B cell growth and differentiation enhancement are mediated by distinct T cell subsets in this system, and raise the possibility that immunoglobulin-dependent TH cells in other systems will routinely exhibit a unique surface antigen profile. These data also imply that immunoglobulin-dependent TH cells (such as the THd cells) may not express antigen receptors that are identical to those expressed by MHC-restricted helper cells (such as our THg cells).
我们之前已经提供了证据,表明在体内增强MOPC-315浆细胞瘤细胞分泌分化的绵羊红细胞免疫辅助性T(TH)细胞(THd细胞),在特异性、辅助细胞需求以及Qa-1表达方面,与在体内增强MOPC-315细胞生长的绵羊红细胞免疫TH细胞(THg细胞)有所不同。实际上,与其他免疫球蛋白依赖性TH细胞一样,315系统中的THd细胞在经抗IgM处理的B细胞缺陷小鼠中无法发育,而THg细胞的发育则不受影响。在本报告中,我们提供了证据证明这两种TH细胞群体在表面抗原表达上存在其他差异。我们发现,与大多数Lyt-1 +、2 - T细胞一样,THg细胞可通过单克隆抗L3T4抗体和补体处理而被清除,而这种处理对绵羊红细胞免疫THd细胞活性的过继转移没有影响。同样,用单克隆抗T细胞受体β链同种异型抗体加抗大鼠IgG和补体处理绵羊红细胞免疫T细胞后,THg细胞活性被清除,而THd细胞活性保持完整。两种辅助细胞活性均可通过抗Lyt-1.2或抗Thy-1.2抗体及补体处理而被消除。有趣的是,用单克隆抗B220或单克隆抗p50抗体(分别为RA3-3A1/6.1和RA3-2C2/1)及补体处理绵羊红细胞免疫T细胞后,THd细胞活性被消除,而THg细胞活性不受影响。额外的对照表明,THd效应并非由于Thy-1 +、B220 - 细胞与Thy-1 -、B220 + 细胞之间的双细胞相互作用产生,因此有人提出THd效应源自表现出独特表型(Thy-1 +、Ly-1 +、2 -、L3T4 -、B220 +)的单一细胞群体。用在体外促进MOPC-315细胞分泌分化且表现出这种表面抗原表型的T细胞克隆进行的研究进一步支持了这一观点。这两种TH细胞群体之间的血清学差异进一步强调了在该系统中B细胞生长和分化增强由不同T细胞亚群介导的可能性,并增加了其他系统中免疫球蛋白依赖性TH细胞通常会表现出独特表面抗原谱的可能性。这些数据还意味着免疫球蛋白依赖性TH细胞(如THd细胞)可能不表达与MHC限制性辅助细胞(如我们的THg细胞)相同的抗原受体。